Can CYP2D6 poor metabolizer (PM) status be ruled out by a single genotyping assay?

被引：0
|
作者：
Gaedigk, A
Bradford, LD
Leeder, JS
机构：
[1] Childrens Mercy Hosp, Sect Dev Pharmacol & Expt Therapeut, Kansas City, MO 64108 USA
[2] Morehouse Sch Med, Atlanta, GA 30310 USA
来源：
DRUG METABOLISM REVIEWS | 2002年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
303
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [1] CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the-1584G promoter polymorphism
    Gaedigk, A
    Ryder, DL
    Bradford, LD
    Lceder, JS
    CLINICAL CHEMISTRY, 2003, 49 (06) : 1008 - 1011
  • [2] CYP2D6*36 gene arrangements within the CYP2D6 locus:: Association of CYP2D6*36 with poor metabolizer status
    Gaedigk, A
    Bradford, LD
    Alander, SW
    Leeder, JS
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 563 - 569
  • [3] CYP2D6 metabolizer status and postoperative analgesia with tramadol
    Wilder-Smith, CH
    Wilkins, J
    ANESTHESIOLOGY, 1999, 91 (3A) : U416 - U416
  • [4] ROLE OF THE CYP2D6 POOR METABOLIZER STATUS ON THE FIBROSIS PROGRESSION AFTER LIVER TRANSPLANTATION
    Zimmermann, T.
    Hoppe-Lotichius, M.
    Koerner, A.
    Lautem, A.
    Galle, P. R.
    Schuchmann, M.
    Otto, G.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 3 - 3
  • [5] CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment
    Almoguera, Berta
    Riveiro-Alvarez, Rosa
    Lopez-Castroman, Jorge
    Dorado, Pedro
    Vaquero-Lorenzo, Concepcion
    Fernandez-Piqueras, Jose
    LLerena, Adrian
    Abad-Santos, Francisco
    Baca-Garcia, Enrique
    Dal-Re, Rafael
    Ayuso, Carmen
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (11): : 627 - 630
  • [6] Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer
    Susce, Margaret T.
    Murray-Carmichael, Elaina
    de Leon, Jose
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (07): : 1356 - 1358
  • [7] Unique case of serotonin toxicity in a poor CYP2D6 metabolizer
    Feininger, E. Sterling
    Dulaney, Anna
    Sanders, Taylor
    Pikus, Angela
    Kopec, Kathryn
    CLINICAL TOXICOLOGY, 2023, 61 : 71 - 71
  • [8] Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer status
    Barclay, ML
    Sawyers, SM
    Begg, EJ
    Zhang, M
    Roberts, RL
    Kennedy, MA
    Elliott, JM
    PHARMACOGENETICS, 2003, 13 (10): : 627 - 632
  • [9] ASSOCIATION OF CYP2D6 METABOLIZER STATUS WITH ANTIDEPRESSANT INDUCED MANIA
    Beaupre, Lindsay Melhuish
    Zai, Clement
    Tiwari, Arun
    Mundo, Emanuela
    Shaikh, Sajid
    Tampakeras, Maria
    Freeman, Natalie
    Kennedy, James L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S865 - S865
  • [10] Change from the CYP2D6 extensive metabolizer to the poor metabolizer phenotype during treatment with bupropion
    Güzey, C
    Nordström, Å
    Spigset, O
    THERAPEUTIC DRUG MONITORING, 2002, 24 (03) : 436 - 437
12345